To include your compound in the COVID-19 Resource Center, submit it here.

MP4OX: Phase IIa data

In a double-blind, international Phase IIa trial in 51 severely injured trauma patients with lactic acidosis, 250 and 500 mL MP4OX each met

Read the full 235 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE